Generate Biomedicines, Inc. Common Stock — 四半期決算報告書 (NASDAQ:GENB)

チャート全体を表示 Full chart

Financials

概要明細書統計

期次年次

Market Capitalization 1.6909 B
Employee 312
Founded 2018
CEO N/A
Website www.generatebiomedicines.com
Headquarter Delaware, United States
FIGI BBG00X9D0NZ0
Industry 医薬品メーカー（一般）

総売上高

当期純利益

1株当たり基本利益（基本EPS）

有利子負債合計

フリーキャッシュフロー

現金および現金同等物

Generate Biomedicines, Inc. - Common Stock

Generate:Biomedicines is a biotechnology company founded in 2018 and headquartered in Somerville, Massachusetts. It specializes in using machine learning to design and optimize proteins for therapeutic applications, with a focus on immunology, oncology, and infectious diseases.